Status | Study |
Completed |
Study Name: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS Condition: Atypical Hemolytic Uremic Syndrome Date: 2009-02-12 Interventions: Drug: eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Study Name: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome Date: 2009-02-03 Interventions: Drug: eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Study Name: Sensitivity and Specificity of NGAL in an Emergency Room Population Condition: Azotemia Renal Insufficiency, Chronic Date: 2008-11-05 |
Completed |
Study Name: Rituximab in Patients With Relapsed or Refractory TTP-HUS Condition: Thrombotic Thrombocytopenic Purpura Hemolytic Uremic Syndrome Date: 2007-09-17 Interventions: Drug: Rituximab Rituximab will be administered on weeks 1, 2, 3, and 4 at a dose of 375 mg/m2 per infusi |
Terminated |
Study Name: Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome Condition: Hemolytic Uremic Syndrome Date: 1999-10-18 Interventions: Drug: SYNSORB Pk Other Name: O |